MMIL-R Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2019

Location

Daejeon-City South Korea

Primary Industry

Medical Devices & Equipment

About

Founded in 2019, and based in Daejeon, South Korea, Milal Co., Ltd., doing business as MMIL-R, operates as medical device development and manufacturing company that provides cancer treatment technologies, nerve stimulation, and polyurethane melt injection technology. In March 2022, MMIL-R raised venture funding from returning investor Korea Venture Investment Corporation. As of 2022, the company is led by its CEO, Jinhee Moon. The company offers various medical devices that include MMIL-R 1, an electroporation micro-drug injection, and MMIL-R 2, micro-fusion electrodes that are used to inject drugs into target cells. The company offers artificial intelligence-based electrode manufacturing technology used for nerve stimulation, polyurethane melt injection technology, and many more medical applications. Following the March 2022 acquisition, the company plans to continue its ZTOP IR Scaling Program.

Current Investors

Korea Venture Investment Corporation

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Diagnostic, Medical & Imaging Laboratories, Healthcare IT, Oncology/Cancer Treatment, Diagnostic Equipment

Website

www.mmilr.com

Verticals

Artificial Intelligence, HealthTech, Manufacturing

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.